Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functional areas needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need.

The Backbone of our Innovation

The Dova Board brings impressive experience to the table, bright minds from across the spectrum of relevant disciplines helping to illuminate the path forward for our pharmaceutical solutions.

Alfred J. Novak

Alfred J. Novak

Joined Dova Board: May 2017

Mr. Novak serves on the Board of Directors of LivaNova PLC, a NASDAQ listed, medical device company based in London. Previously he has served on the Boards of Cyberonics, Inc., OrbusNeich Medical Technology Company, Ltd., ProRhythym, Inc., Sutura, Inc., Novoste Corporation and Biosense, Inc. From April 2014 until March 2015, Mr. Novak served as President and Chief Executive Officer of Syntheon Cardiology, LLC, an early-stage company developing a percutaneous prosthetic aortic heart valve. In 1998, he was a founder of Syntheon, LLC, a privately held company that focused on minimally invasive medical devices for the gastroenterology and vascular markets. Mr. Novak experience includes being CEO and CFO of public and private companies based in the US, Europe and Hong Kong. He graduated from the United States Merchant Marine Academy and received his M.B.A. from the Wharton School, University of Pennsylvania.